A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis
Top Cited Papers
- 1 May 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6746) , eadp5540
Abstract
The gut microbiota is known to be associated with a variety of human metabolic diseases, including metabolic dysfunction–associated steatohepatitis (MASH). Fungi are increasingly recognized as important members of this community; however, the role of fungal symbionts in metabolic diseases is unknown. We have systematically isolated and characterized gut fungi, identifying Fusarium foetens as an intestinal symbiotic filamentous fungus in mice. F. foetens reverses MASH progression in mouse models through an intestinal ceramide synthetase 6 (CerS6)–ceramide axis. Moreover, we identified FF-C1, a secondary metabolite from F. foetens , as a CerS6 inhibitor that has an endogenous protective effect on MASH progression.Keywords
This publication has 78 references indexed in Scilit:
- Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathwayCell, 2024
- Investigation of culturable human gut mycobiota from the segamat community in Johor, MalaysiaWorld Journal of Microbiology and Biotechnology, 2021
- Culturable mycobiota from Karst caves in China II, with descriptions of 33 new speciesFungal Diversity, 2020
- Nonalcoholic SteatohepatitisJAMA, 2020
- Tsaokopyranols A–M, 2,6-epoxydiarylheptanoids from Amomum tsao-ko and their α-glucosidase inhibitory activityBioorganic Chemistry, 2020
- Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic HepatitisHepatology, 2019
- Natural product discovery: past, present, and futureJournal of Industrial Microbiology and Biotechnology, 2016
- Hydration Effects on Skin Microstructure as Probed by High-Resolution Cryo-Scanning Electron Microscopy and Mechanistic Implications to Enhanced Transcutaneous Delivery of BiomacromoleculesJournal of Pharmaceutical Sciences, 2010
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Metabolites of Fusarium solaniPhytochemistry, 1989